Annals of Indian Academy of Neurology
VIEW POINT
Year
: 2019  |  Volume : 22  |  Issue : 2  |  Page : 131--136

Can we treat secondary progressive multiple sclerosis now?


Rohit Bhatia, Nishita Singh 
 Department of Neurology, All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
Dr. Rohit Bhatia
Department of Neurology, Neurosciences Centre, All India Institute of Medical Sciences, New Delhi - 110 029
India

Secondary progressive multiple sclerosis (SPMS) is characterized by progressive accumulation of disability without intermittent recovery. Treatment of these patients is challenging due to limited understanding of pathogenesis and fewer therapeutic options. This article summarizes difficulties in defining and conducting trials in SPMS, review major clinical trials on therapies approved and unapproved in SPMS and lastly, therapies in pipeline for use in SPMS.


How to cite this article:
Bhatia R, Singh N. Can we treat secondary progressive multiple sclerosis now?.Ann Indian Acad Neurol 2019;22:131-136


How to cite this URL:
Bhatia R, Singh N. Can we treat secondary progressive multiple sclerosis now?. Ann Indian Acad Neurol [serial online] 2019 [cited 2019 Jun 17 ];22:131-136
Available from: http://www.annalsofian.org/article.asp?issn=0972-2327;year=2019;volume=22;issue=2;spage=131;epage=136;aulast=Bhatia;type=0